Indegene Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Indegene Ltd. on BSE

Load latest

Indegene Ltd.

24 Jan 2025

575.80

-0.47%

Board Meeting

Indegene Ltd - 544172 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 …

BSE India

Indegene Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2025 ,inter alia, to consider and approve 1. The unaudited consolidated financial results of the Company and its subsidiaries as per Indian Accounting Standards (INDAS) for the quarter December 31 ,2024 along with the limited review report of the Auditors thereon. 2. The unaudited standalone financial results of the Company as per INDAS for the quarter December 31,2024 along with the limited review report of the Auditors thereon. 3. Appointment of statutory auditor for five financial years commencing from 2025-26 and to hold such office till the conclusion of Annual General Meeting to be held for the Financial Year 2029-30. 4. Approval of allotment under ESOP Scheme 2020, RSU Scheme 2020

pdf

Indegene Ltd.

23 Jan 2025

575.80

-0.47%

Company Update

Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

Intimation of grant under company stock option schemes.

pdf

Indegene Ltd.

20 Jan 2025

575.80

-0.47%

Company Update

Indegene Ltd - 544172 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2024.

pdf

Indegene Ltd.

17 Jan 2025

575.80

-0.47%

Company Update

Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Indegene wins Big Innovation Award January 2025

pdf

Indegene Ltd.

09 Jan 2025

575.80

-0.47%

Company Update

Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Pursuant to Regulation 30 of the SEBI [LODR] Regulation, 2015, enclosed herewith is a press release dated January 09,2025, titled ''CliniOps Announces strategic partnership with Indegene to Accelerate Clinical Trails''.

pdf

Indegene Ltd.

30 Dec 2024

575.80

-0.47%

SAST

Indegene Ltd - 544172 - Closure of Trading Window

BSE India

Pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 and the company''s code of conduct for regulating monitoring and reporting of trading by insiders, the trading window for dealing in the securities of the company by its designated persons will remain closed from Wednesday January 1, 2025 in connection with the finalization and approval of financial results for the quarter ending December 31, 2024

pdf

Indegene Ltd.

27 Dec 2024

575.80

-0.47%

Company Update

Indegene Ltd - 544172 - Disclosure As Per Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) …

BSE India

Pursuant to regulation 7(2)(b) of SEBI PIT regulations 2015 we are enclosing herewith the disclosures received by the company under Regulation 7(2)(a) of the PIT regulations from Designated Persons of the company in Form C with respect to sale of equity shares of the company

pdf

Indegene Ltd.

27 Dec 2024

575.80

-0.47%

Company Update

Indegene Ltd - 544172 - Intimation Of Outcome Of Resolution Passed By Circulation Under Regulation 30 …

BSE India

Pursuant to Regulation 30 of SEBI LODR Regulations 2015 we are enclosing herewith the following resolutions of Board of Directors of Indegene Limited were passed by circulation on Wednesday December 25 2024.

pdf